Meropenem: continuous or extended infusion?

被引：3
|
作者：
Frippiat, Frederic [1 ,2 ]
Vercheval, Christelle [3 ]
Layios, Nathalie [4 ]
机构：
[1] Univ Hosp Liege, Div Infect Dis, Dept Internal Med, Liege, Belgium
[2] CHU Liege, Serv Malad Infect, Ave Hop,1-B35, B-4000 Liege, Belgium
[3] Univ Hosp Liege, Dept Clin Pharm, Liege, Belgium
[4] Univ Hosp Liege, Dept Intens Care Unit, Liege, Belgium
来源：
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词：
D O I：
10.1186/s13054-020-02883-w
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill Patients
    Ahmed, Nabeela
    Jen, Shin-Pung
    Altshuler, Diana
    Papadopoulos, John
    Pham, Vinh P.
    Dubrovskaya, Yanina
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (08) : 763 - 771
  • [32] A Comparison of Two Regimens (Extended Versus Short Infusion) of Meropenem in an Intensive Care Unit
    Mathew, S. K.
    Mathew, B. S.
    Naik, G. S.
    Gupta, R. P.
    Subramani, K.
    Jacob, G. G.
    Fleming, D. H.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 697 - 697
  • [33] A Retrospective Analysis of Intravenous Push versus Extended Infusion Meropenem in Critically Ill Patients
    Johnson, Emory G.
    Ortiz, Kayla Maki
    Adams, David T.
    Kaur, Satwinder
    Faust, Andrew C.
    Yang, Hui
    Alvarez, Carlos A.
    Hall, Ronald G.
    ANTIBIOTICS-BASEL, 2024, 13 (09):
  • [34] Chemical stability and physical compatibility of meropenem in admixtures for continuous and extended intravenous infusions
    Gimenez-Giner, Sara
    Llopis-Alemany, Antoni
    Porta-Oltra, Begona
    Llopis-Salvia, Pilar
    Climente-Marti, Monica
    Martinez-Gomez, Maria Amparo
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (10): : 612 - 616
  • [35] Pharmacokinetics of Continuous-Infusion Meropenem in a Pediatric Patient Receiving Extracorporeal Life Support
    Cies, Jeffrey J.
    Moore, Wayne S., II
    Dickerman, Mindy J.
    Small, Christine
    Carella, Dominick
    Chopra, Arun
    Parker, Jason
    PHARMACOTHERAPY, 2014, 34 (10): : E175 - E179
  • [36] Therapeutic drug monitoring of meropenem and piperacilin administered in continuous infusion. preliminary data
    M Miralbés Torner
    F Ahmad Diaz
    S Carvalho Brugger
    SM Cano Marron
    JA Schoenenberger
    A Aragones Eroles
    X Nuvials Casals
    M Vallverdu Vidal
    B Balsera Garrido
    M Palomar Martinez
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [37] Pharmacokinetics of Continuous-Infusion Meropenem for the Treatment of Serratia marcescens Ventriculitis in a Pediatric Patient
    Cies, Jeffrey J.
    Moore, Wayne S., II
    Calaman, Sharon
    Brown, Melandee
    Narayan, Prithvi
    Parker, Jason
    Chopra, Arun
    PHARMACOTHERAPY, 2015, 35 (04): : E32 - E36
  • [38] Efficacy and Safety of Extended Continuous-Infusion Neostigmine
    Foris, L.
    Samad, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study
    Tien, Nguyen Tran Nam
    Binh, Vu Ngan
    Ha, Pham Thi Thanh
    Lan, Dang Thi Ngoc
    Cho, Yong-Soon
    Long, Nguyen Phuoc
    Shin, Jae-Gook
    Anh, Nguyen Hoang
    Quan, Truong Anh
    Tuan, Do Ngoc
    Tiep, Nguyen Khac
    Thach, Pham The
    Anh, Nguyen Hoang
    Hoa, Vu Dinh
    PLOS ONE, 2024, 19 (12):
  • [40] Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
    F Thalhammer
    F Traunmüller
    M Frass
    UM Hollenstein
    GJ Locker
    T Staudinger
    H Burgmann
    Critical Care, 3 (Suppl 1):
12345